Explore more publications!
UK Daily Ledger
Got News to Share?

UK Daily Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Daily Ledger.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on January 8, 2026

VivoPower Appoints Rachel Pether, Sovereign Wealth Fund Expert, to Global Advisory Council
Jan. 8, 2026

VivoPower Appoints Rachel Pether, Sovereign Wealth Fund Expert, to Global Advisory Council

Indeterminate GlobeNewswire
St John Ambulance partners with Simpson Associates to build the foundations for data transformation
Jan. 8, 2026

St John Ambulance partners with Simpson Associates to build the foundations for data transformation

Indeterminate GlobeNewswire
Online Event Ticketing Market Competition Analysis 2026: How Players Are Shaping Growth
Jan. 8, 2026

Online Event Ticketing Market Competition Analysis 2026: How Players Are Shaping Growth

Indeterminate EIN Presswire
Power Grid System Market Competition Analysis 2026: How Players Are Shaping Growth
Jan. 8, 2026

Power Grid System Market Competition Analysis 2026: How Players Are Shaping Growth

Indeterminate EIN Presswire
Projectors Market Competition Analysis 2026: How Players Are Shaping Growth
Jan. 8, 2026

Projectors Market Competition Analysis 2026: How Players Are Shaping Growth

Indeterminate EIN Presswire
Culture Houses Transform Public Libraries in Saudi Arabia, Welcoming Over 864,000 Visitors
Jan. 8, 2026

Culture Houses Transform Public Libraries in Saudi Arabia, Welcoming Over 864,000 Visitors

Indeterminate EIN Presswire
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
Jan. 8, 2026

Indivior Provides Full-Year 2026 Financial Guidance and Business Update

Indeterminate GlobeNewswire
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
Jan. 8, 2026

CMR Surgical receives CE Mark for use of Versius in paediatric surgery

Indeterminate GlobeNewswire
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
Jan. 8, 2026

Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study

Indeterminate GlobeNewswire
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
Jan. 8, 2026

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)

Indeterminate GlobeNewswire
Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies
Jan. 8, 2026

Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies

Indeterminate GlobeNewswire
BizClik Launches January 2026 Sustainability Portfolio With Insights From Novartis and Amazon
Jan. 8, 2026

BizClik Launches January 2026 Sustainability Portfolio With Insights From Novartis and Amazon

Indeterminate GlobeNewswire
Energys Group Announces Receipt of Determination Letter from Nasdaq Capital Market
Jan. 8, 2026

Energys Group Announces Receipt of Determination Letter from Nasdaq Capital Market

Indeterminate GlobeNewswire
Human Appeal’s new subsidiary, The Waqf Fund, launched into $700 billion global market
Jan. 8, 2026

Human Appeal’s new subsidiary, The Waqf Fund, launched into $700 billion global market

Indeterminate GlobeNewswire
NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s
Jan. 8, 2026

NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s

Indeterminate GlobeNewswire
EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome
Jan. 8, 2026

EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome

Indeterminate GlobeNewswire
Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis
Jan. 8, 2026

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis

Indeterminate GlobeNewswire
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
Jan. 8, 2026

Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

Indeterminate GlobeNewswire
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
Jan. 8, 2026

CMR Surgical receives CE Mark for use of Versius in paediatric surgery

Indeterminate GlobeNewswire
Shell fourth quarter 2025 update note
Jan. 8, 2026

Shell fourth quarter 2025 update note

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions